Neurocrine Biosciences Inc (NBIX)

Return on assets (ROA)

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net income	US$ in thousands	249,700	154,500	89,600	407,300	37,000
Total assets	US$ in thousands	3,251,400	2,368,700	2,072,500	1,734,700	1,306,000
ROA		7.68%	6.52%	4.32%	23.48%	2.83%

December 31, 2023 calculation

ROA = Net income ÷ Total assets
= $249,700K ÷ $3,251,400K
= 7.68%

Neurocrine Biosciences, Inc.'s return on assets (ROA) has shown fluctuations over the past five years. The company's ROA was 7.68% as of December 31, 2023, indicating that for every dollar of assets, the company generated a return of 7.68 cents.

Comparing this to the previous years, there has been a general upward trend in ROA since 2019 when it was 2.83%. This suggests that the company has been more effective in utilizing its assets to generate profits over the last five years.

The peak ROA of 23.48% in 2020 was notably high, indicating a strong performance in asset utilization that year. However, the ROA decreased in 2021 to 4.32% before increasing to 6.52% in 2022 and further to 7.68% in 2023.

Overall, Neurocrine Biosciences, Inc.'s ROA has been relatively healthy, with fluctuations reflecting changes in the company's asset management efficiency and profitability over the years.